Shao Zonghong
Prọfesọ, Onyeisi Dọkịta, Onye Nlekọta Dọkịta, ọkachamara n'ihe gbasara ọbara a ma ama n'obodo niile. Ọ bụ ugbu a Onyeisi nke Ngalaba Hematology na Onyeisi nke Ngalaba Izi na Nnyocha nke Ọgwụ Ime. Ọ bụ Osote Onyeisi nke Ngalaba Hematology nke Òtù Ahụike China; Osote Onyeisi nke Ngalaba Hematologists nke Òtù Ahụike China; Onyeisi oche nke Ngalaba Hematology Immunology nke Òtù Immunology nke China na Onyeisi nke Òtù Cytometry Clinical Flow; Onye otu Kọmitii Na-eguzobe nke Òtù Ahụike Tianjin; Onyeisi nke Ngalaba Hematology nke Òtù Ahụike Tianjin; Onyeisi nke Kọmitii Mbugharị Ọbara nke Tianjin; Onye isi oche nke Kọmitii Mbugharị Ọbara nke Njikọ Ọbara Tianjin; Onye otu Kọmitii Na-eguzobe nke Òtù Ndị Ọrụ Ọrịa Kansa nke China (CSCO); Onyeisi nke Òtù Mbugharị Ọbara China; Ọkachamara n'inyocha ihe mberede ahụike nke Òtù Ahụike China; Onyeisi nke Òtù Ahụike China. Onyeisi nke Òtù Mbugharị Ọbara China (CBTA); Ọkachamara nke Nyocha Nkà na Ụzụ Ahụike nke Òtù Ahụike China (CMA); Onye otu Kọmitii Nyocha Sayensị Ahụike na Teknụzụ China; Onye otu Kọmitii Nyocha Ọgwụ na Nkà na Ụzụ Ọgwụ nke Òtù Ọgwụ na Biotechnology nke China (CPBTA); Onye otu Kọmitii Gerontological Society of Geriatric Oncology; Ọkachamara nke Ministry of Health (MOH) Clinical Pathway Technical Audit Expert; Ọkachamara nke Tianjin Municipal Clinical Application of Medical Technology Audit Expert; Onye otu mba ofesi nke American Society of Blood Ọ bụkwa onye otu mba ofesi nke American Society of Hematology. Ọ rụọla ọrụ dịka osote onye nchịkọta akụkọ, osote onye nchịkọta akụkọ na onye otu bọọdụ nchịkọta akụkọ nke ihe karịrị akwụkwọ akụkọ ọkachamara iri nke mba, gụnyere Chinese Journal of Hematology, na dịka onye nyocha mba ofesi nke akwụkwọ akụkọ Blood. Ọ gara United States maka njem ọmụmụ abụọ na 1989-1992 na 1998, ọ gara Europe na United States maka ọtụtụ njem ọmụmụ na mgbanwe agụmakwụkwọ.
Ọ gụsịrị akwụkwọ na Fudan University School of Medicine (bụbu Shanghai Medical University) na 1982. Ọ bụ ọkachamara n'ịchọpụta na ịgwọ ọrịa dị iche iche dị n'ọbara, ọkachasị na "aplastic anaemia", "myelodysplastic syndromes", "immune-associated hemopenia", "paroxysmal sleep apnea" na "paroxysmal sleep apnea", "Paroxysmal Sleeping Hemoglobinuria", "High Dose Chemotherapy for Leukemia", "Refractory Hematopenia (dịka Immune Thrombocytopenia)", "Ihe ndị o mere na nchọpụta na ọrịa hematopoietic oncological (ọtụtụ myeloma, lymphoma, wdg) na coagulation disorders dị egwu, ha dịkwa n'ọkwa kachasị elu na China na ọkwa dị elu n'ụwa. Ọ chịkwara ọrụ 19 nke mba, nke minista, nke mpaghara na nke obodo, natara ihe karịrị onyinye sayensị 10, bipụta ihe karịrị akwụkwọ agụmakwụkwọ 300, ma dezie akwụkwọ 25 na akwụkwọ ọgụgụ gbasara hematology. A gọziri ya dịka "Onye dị elu nke Peking Union Medical College, Ụlọ Akwụkwọ Sayensị Ahụike nke China”, “Ndị Ọrụ Sayensị na Teknụzụ Ndị Na-eto Eto Iri Pụrụ Iche nke Tianjin”, “Atụmatụ Afọ Ise nke Tianjin nke Itoolu”, “Atụmatụ Afọ Ise nke Iri”, na “Atụmatụ Afọ Ise nke Iri”. “Ihe nrite nke Uru na Atụmatụ Afọ Ise nke Tianjin nke Itoolu na nke Iri na Ise”, ‘Onye Ọrụ Nlereanya Tianjin’, ‘Onye Nkụzi Pụrụ Iche nke Tianjin’, “Onye Nkụzi A Ma Ama nke Mahadum Ahụike Tianjin”, ‘Onye Nkụzi A Ma Ama nke Ụlọ Ọgwụ Ọgwụ Mahadum Tianjin’, ‘Dọkịta Ọma Mbụ na Ụlọ Ọrụ Ahụike Ndị Mmadụ Tianjin Mere Afọ Ojuju’, “Ndị Isi Ngalaba Iri Kasị Elu nke Ụlọ Ọgwụ Ọgwụ Mahadum Tianjin” na ndị ọzọ.
